Auriga Reiterates a 'Buy' on Illumina (ILMN); Adjusting Estimates on Preannouncement
Tweet
Share
E-mailGet Alerts ILMN Hot Sheet
Price: $118.29 --0%
Rating Summary:
16 Buy, 19 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 15
Rating Summary:
16 Buy, 19 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 15
Join SI Premium – FREE
Auriga reiterates a 'Buy' on Illumina (NASDAQ: ILMN) price target of $60.00.
Analyst, Peter McDonald, said, "For 1Q12, ILMN expects revenues of ~$270MM, ahead of street consensus ($258MM) and our $254MM estimate, as well as the quarterly guidance. ILMN noted across the board strength and highlighted a book-to-bill ratio over 1.1. Overall, we believe these results reflect a number of positive drivers and bode well for the outlook in 2012. In the interim, we continue to expect the deal with Roche will be consummated -- however the price needs to be higher -- reflecting ILMN's leadership position, product pipeline, and potential commercial opportunities in clinical diagnostics."
For an analyst ratings summary and ratings history on Illumina click here. For more ratings news on Illumina click here.
Shares of Illumina closed at $52.62 yesterday.
Analyst, Peter McDonald, said, "For 1Q12, ILMN expects revenues of ~$270MM, ahead of street consensus ($258MM) and our $254MM estimate, as well as the quarterly guidance. ILMN noted across the board strength and highlighted a book-to-bill ratio over 1.1. Overall, we believe these results reflect a number of positive drivers and bode well for the outlook in 2012. In the interim, we continue to expect the deal with Roche will be consummated -- however the price needs to be higher -- reflecting ILMN's leadership position, product pipeline, and potential commercial opportunities in clinical diagnostics."
For an analyst ratings summary and ratings history on Illumina click here. For more ratings news on Illumina click here.
Shares of Illumina closed at $52.62 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Upgrades Oxford Biomedica (OXB:LN) (OXBDF) to Buy
- J.B. Hunt Transport Services (JBHT) PT Lowered to $200 at Benchmark
- AudioEye (AEYE) PT Raised to $17 at H.C. Wainwright
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
